{
  "resourceType": "Task",
  "id": "mii-exa-molgen-medikationsempfehlung-fgfr2-fusion",
  "meta": {
    "profile": [
      "https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/medikationsempfehlung|2026.0.3",
      "http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/medication-recommendation|3.0.0"
    ]
  },
  "status": "requested",
  "intent": "proposal",
  "basedOn": [
    {
      "reference": "ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"
    }
  ],
  "code": {
    "coding": [
      {
        "code": "LA26421-0",
        "system": "http://loinc.org",
        "display": "Consider alternative medication"
      }
    ],
    "text": "Hochselektive FGFR-Inhibitor-Therapie"
  },
  "for": {
    "reference": "Patient/mii-exa-molgen-patient-fgfr2-fusion"
  },
  "reasonReference": {
    "reference": "Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"
  }
}
